Show simple item record

dc.contributor.authorAshander, Liam M
dc.contributor.authorAppukuttan, Binoy
dc.contributor.authorMa, Yuefang
dc.contributor.authorGardner-Stephen, Dione Anne
dc.date.accessioned2016-10-21T05:31:40Z
dc.date.available2016-10-21T05:31:40Z
dc.date.issued2016
dc.identifier.citationAshander LM, Appukuttan B, Ma Y, Gardner-Stephen D, Smith JR. Targeting Endothelial Adhesion Molecule Transcription for Treatment of Inflammatory Disease: A Proof-of-Concept Study. Mediators of Inflammation. 2016;2016:7945848. doi:10.1155/2016/7945848.en
dc.identifier.issn0962-9351
dc.identifier.urihttp://hdl.handle.net/2328/36444
dc.descriptionThis is an open access article distributed under the Creative Commons Attribution License (CC BY 4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.en
dc.description.abstractTargeting the endothelial adhesion molecules that control leukocyte trafficking into a tissue has been explored as a biological therapy for inflammatory diseases. However, these molecules also participate in leukocyte migration for immune surveillance, and inhibiting the physiological level of an adhesion molecule might promote infection or malignancy. We explored the concept of targeting endothelial adhesion molecule transcription during inflammation in a human system. Intercellular adhesion molecule 1 (ICAM-1) mediates leukocyte migration across the retinal endothelium in noninfectious posterior uveitis. We observed an increase in the transcription factor, nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (NF-κB1), in parallel with ICAM-1, in human retinal endothelial cells treated with tumor necrosis factor-alpha (TNF-α), and identified putative binding sites for NF-κB1 within the ICAM-1 regulatory region. We targeted induced NF-κB1 expression in endothelial cells with small interfering (si)RNA. Knockdown of NF-κB1 significantly decreased cell surface expression of ICAM-1 protein induced by TNF-α but did not reduce constitutive ICAM-1 expression. Consistently, NF-κB1 knockdown significantly reduced leukocyte binding to cell monolayers in the presence of TNF-α but did not impact baseline binding. Findings of this proof-of-concept study indicate that induced transcription of endothelial adhesion molecules might be targeted therapeutically for inflammatory disease in humans.en
dc.language.isoen
dc.publisherHindawi Publishing Corporationen
dc.rightsCopyright © 2016 Liam M. Ashander et al.en
dc.titleTargeting Endothelial Adhesion Molecule Transcription for Treatment of Inflammatory Disease: A Proof-of-Concept Studyen
dc.typeArticleen
dc.identifier.doihttps://doi.org/10.1155/2016/7945848en
dc.rights.holderThe authors.en


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record